Literature DB >> 22728383

Celiac disease: advances in treatment via gluten modification.

Samantha Stoven1, Joseph A Murray, Eric Marietta.   

Abstract

Celiac disease (CD) is an autoimmune enteropathy that occurs in genetically susceptible individuals carrying the prerequisite genetic markers HLA DQ2 or DQ8. These genetic markers are present in approximately 30% of the population, and the worldwide prevalence of CD is estimated to be approximately 1%-2%. Currently a gluten-free diet is the only treatment for CD, but novel therapies aimed at gluten modification are underway. This review will discuss gluten-based therapies including wheat alternatives and wheat selection, enzymatic alteration of wheat, oral enzyme supplements, and polymeric binders as exciting new therapies for treatment of CD.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22728383      PMCID： PMC3788609          DOI： 10.1016/j.cgh.2012.06.005

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  19 in total

1.  Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients.

Authors:  Raffaella Di Cagno; Maria De Angelis; Salvatore Auricchio; Luigi Greco; Charmaine Clarke; Massimo De Vincenzi; Claudio Giovannini; Massimo D'Archivio; Francesca Landolfo; Giampaolo Parrilli; Fabio Minervini; Elke Arendt; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

2.  Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.

Authors:  Carmen Gianfrani; Rosa A Siciliano; Angelo M Facchiano; Alessandra Camarca; Maria F Mazzeo; Susan Costantini; Virginia M Salvati; Francesco Maurano; Giuseppe Mazzarella; Gaetano Iaquinto; Paolo Bergamo; Mauro Rossi
Journal:  Gastroenterology       Date:  2007-06-20       Impact factor: 22.682

3.  Pasta made from durum wheat semolina fermented with selected lactobacilli as a tool for a potential decrease of the gluten intolerance.

Authors:  Raffaella di Cagno; Maria de Angelis; Giuditta Alfonsi; Massimo de Vincenzi; Marco Silano; Olimpia Vincentini; Marco Gobbetti
Journal:  J Agric Food Chem       Date:  2005-06-01       Impact factor: 5.279

4.  A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.

Authors:  Carlo Catassi; Elisabetta Fabiani; Giuseppe Iacono; Cinzia D'Agate; Ruggiero Francavilla; Federico Biagi; Umberto Volta; Salvatore Accomando; Antonio Picarelli; Italo De Vitis; Giovanna Pianelli; Rosaria Gesuita; Flavia Carle; Alessandra Mandolesi; Italo Bearzi; Alessio Fasano
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

5.  Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients.

Authors:  Liesbeth Spaenij-Dekking; Yvonne Kooy-Winkelaar; Peter van Veelen; Jan Wouter Drijfhout; Harry Jonker; Loek van Soest; Marinus J M Smulders; Dirk Bosch; Luud J W J Gilissen; Frits Koning
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

6.  Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.

Authors:  Dariusz Stepniak; Liesbeth Spaenij-Dekking; Cristina Mitea; Martine Moester; Arnoud de Ru; Renee Baak-Pablo; Peter van Veelen; Luppo Edens; Frits Koning
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05-11       Impact factor: 4.052

7.  Celiac disease: in vitro and in vivo safety and palatability of wheat-free sorghum food products.

Authors:  Carolina Ciacci; Luigi Maiuri; Nicola Caporaso; Cristina Bucci; Luigi Del Giudice; Domenica Rita Massardo; Paola Pontieri; Natale Di Fonzo; Scott R Bean; Brian Ioerger; Marco Londei
Journal:  Clin Nutr       Date:  2007-08-24       Impact factor: 7.324

8.  Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease.

Authors:  C Mitea; R Havenaar; J Wouter Drijfhout; L Edens; L Dekking; F Koning
Journal:  Gut       Date:  2007-05-09       Impact factor: 23.059

9.  Wheat deficient in gliadins: promising tool for treatment of coeliac disease.

Authors:  M Frisoni; G R Corazza; D Lafiandra; E De Ambrogio; C Filipponi; F Bonvicini; E Borasio; E Porceddu; G Gasbarrini
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

10.  Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue.

Authors:  Jonathan Gass; Michael T Bethune; Matthew Siegel; Andrew Spencer; Chaitan Khosla
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682
View more
  15 in total

Review 1.  Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives.

Authors:  Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2013-11-02       Impact factor: 4.200

2.  Celiac disease: a challenging disease for pharmaceutical scientists.

Authors:  Simon Matoori; Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2012-12-11       Impact factor: 4.200

3.  Interest in medical therapy for celiac disease.

Authors:  Christina A Tennyson; Suzanne Simpson; Benjamin Lebwohl; Suzanne Lewis; Peter H R Green
Journal:  Therap Adv Gastroenterol       Date:  2013-09       Impact factor: 4.409

4.  Rapid isolation of gluten-digesting bacteria from human stool and saliva by using gliadin-containing plates.

Authors:  Martina Berger; Christos Sarantopoulos; Deryn Ongchangco; Jeremy Sry; Thomas Cesario
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-16

Review 5.  Current and emerging therapy for celiac disease.

Authors:  Govind K Makharia
Journal:  Front Med (Lausanne)       Date:  2014-03-24

Review 6.  Biomarkers to Monitor Gluten-Free Diet Compliance in Celiac Patients.

Authors:  María de Lourdes Moreno; Alfonso Rodríguez-Herrera; Carolina Sousa; Isabel Comino
Journal:  Nutrients       Date:  2017-01-06       Impact factor: 5.717

7.  Development of TaqMan probes targeting the four major celiac disease epitopes found in α-gliadin sequences of spelt (Triticum aestivum ssp. spelta) and bread wheat (Triticum aestivum ssp. aestivum).

Authors:  Benjamin Dubois; Pierre Bertin; Yordan Muhovski; Emmanuelle Escarnot; Dominique Mingeot
Journal:  Plant Methods       Date:  2017-09-06       Impact factor: 4.993

8.  Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology.

Authors:  Jonas F Ludvigsson; Julio C Bai; Federico Biagi; Timothy R Card; Carolina Ciacci; Paul J Ciclitira; Peter H R Green; Marios Hadjivassiliou; Anne Holdoway; David A van Heel; Katri Kaukinen; Daniel A Leffler; Jonathan N Leonard; Knut E A Lundin; Norma McGough; Mike Davidson; Joseph A Murray; Gillian L Swift; Marjorie M Walker; Fabiana Zingone; David S Sanders
Journal:  Gut       Date:  2014-06-10       Impact factor: 23.059

Review 9.  Digestive Enzyme Supplementation in Gastrointestinal Diseases.

Authors:  Gianluca Ianiro; Silvia Pecere; Valentina Giorgio; Antonio Gasbarrini; Giovanni Cammarota
Journal:  Curr Drug Metab       Date:  2016       Impact factor: 3.731

10.  Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing.

Authors:  María de Lourdes Moreno; Ángel Cebolla; Alba Muñoz-Suano; Carolina Carrillo-Carrion; Isabel Comino; Ángeles Pizarro; Francisco León; Alfonso Rodríguez-Herrera; Carolina Sousa
Journal:  Gut       Date:  2015-11-25       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.